Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cryptococcus Neoformans
100%
Cryptococcosis
100%
Immunoglobulin M
100%
Improved Survival
100%
Systemic Infection
100%
Secretory Immunoglobulin A (SIgA)
100%
Neoformans
66%
Secretory IgM
66%
Gene-deficient Mice
50%
Glucuronoxylomannan
50%
B Cells
33%
CD5+
33%
Mouse Strain
33%
Enhanced Resistance
16%
Interferon-α (IFN-α)
16%
Immunocompromised Patients
16%
AIDS/HIV
16%
C57BL
16%
Nave
16%
Murine Model
16%
Post-infection
16%
Interleukin-6
16%
Tumor Necrosis Factor-α
16%
T Cell Subsets
16%
Interleukin-1β
16%
Serum Levels
16%
Fatal Infection
16%
Antibody Response
16%
Serum IgM
16%
Inflammatory Mediators
16%
Flow Cytometry
16%
Serum Antibody
16%
Splenocytes
16%
Capsular Polysaccharide
16%
Splenic B Cells
16%
High Titer
16%
Interleukin-10
16%
Antifungal Activity
16%
T Cell Immunity
16%
Interferon-γ
16%
MIP-1b
16%
Intraperitoneal Infection
16%
IgG2a
16%
Interleukin-13 (IL-13)
16%
B Cell Subsets
16%
Antibody Profile
16%
Fungicidal Activity
16%
Anti-inflammatory Mediators
16%
Natural Disease
16%
B-1 Cells
16%
Inflammatory Milieu
16%
Low Serum
16%
Cytokines/chemokines
16%
Immunology and Microbiology
Cryptococcus neoformans
100%
Immunoglobulin M
100%
Infectious Disease
100%
Secretory Immunoglobulin
100%
Infection
100%
Mediator
22%
B Cell
22%
CD5
22%
Mouse Strain
22%
Interleukin 6
11%
Cytokine
11%
Tumor Necrosis Factor Alpha
11%
T Cell Subset
11%
Interleukin 1
11%
Blood Level
11%
Chemokine
11%
Antibody Response
11%
Titer
11%
Splenocyte
11%
Adoptive Immunity
11%
Splenic B Cell
11%
Colony-Forming Unit
11%
Colony Forming Unit S
11%
Antibody Blood Level
11%
Antifungal Activity
11%
Interferon Gamma
11%
Immunocompromised Patient
11%
HIV/AIDS
11%
Peritonitis
11%
Immunoglobulin G2a
11%
Interleukin 10
11%
Interleukin 13
11%
Fungicidal Activity
11%
B-1 Cell
11%
B Cell Subsets
11%
Susceptibility
11%